Patents by Inventor Yitzhak Ben-Asouli

Yitzhak Ben-Asouli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190001332
    Abstract: The present invention provides a disposable 3-D structured depended sequential lateral flow capillary device comprising: a housing; a 3-D structured capillary flow matrix; and (iii) an absorption portion, and use thereof in a method for determining the presence of an analyte in a sample.
    Type: Application
    Filed: December 19, 2016
    Publication date: January 3, 2019
    Applicant: Gene Bio Application Ltd.
    Inventors: Yitzhak Ben Asouli, Farhat Osman
  • Patent number: 8241477
    Abstract: A tank apparatus (10) for horizontal electrophoresis that comprises a base member (12) having at least first and second independent receptacles (16, 18) for accommodating buffer solution. Each of the receptacles comprises an inlet (28, 28?) for allowing communication with the external environment. A cover member (14) covers at least the first and second receptacles, thereby forming first and second buffer chambers. The cover member comprising suitable openings (40, 42) for allowing a portion of an electrophoresis gel cassette to be inserted therethrough, such that the electrophoresis gel is in communication with the contents of each of the first and second receptacles. Each of a pair of electrodes (33, 33?) is situated in one of each of the first and second receptacles, wherein the electrodes are connectable to an electrical power supply.
    Type: Grant
    Filed: January 16, 2006
    Date of Patent: August 14, 2012
    Assignee: Gene Bio-Application Ltd.
    Inventors: Yitzhak Ben-Asouli, Farhat Osman
  • Publication number: 20110308951
    Abstract: Disclosed is a precast polyacrylamide gel for use in gel electrophoresis, comprising polyacrylamide and an aqueous Tris 0.04 M to 0.15 M solution, at least one first ampholyte exhibiting an isoelectric point (pI) of from 5.4 to 6.4 at a total concentration of from 0.01 M to 0.4 M; and at least one second ampholyte exhibiting an isoelectric point (pI) of from 2.5 to 3.5 to adjust the pH to between 5.5 and 7.5 at the temperature of 25° C. The precast gels can be used for electrophoresis of oligopeptides, polypeptides, oligonucleotides, and polynucleotides under denaturating or nondenaturing conditions, and exhibit long shelf-life.
    Type: Application
    Filed: February 25, 2010
    Publication date: December 22, 2011
    Applicant: GENE BIO-APPLICATION LTD.
    Inventors: Yitzhak Ben-Asouli, Farhat Osman
  • Publication number: 20100264031
    Abstract: Provided is a precast polyacrylamide gel for use in gel electrophoresis, having a shelf-life of at least 12 months. The gel comprises a sulfonated tertiary or secondary amine having a pKa of 6.6-8.0, ampholytes exhibiting pI between 5.4 to 6.4, Tris, and hydrochloric acid to adjust the pH to between 5.5 and 7.5.
    Type: Application
    Filed: August 31, 2008
    Publication date: October 21, 2010
    Applicant: GENE BIO-APPLICATION LTD.
    Inventors: Farhat Osman, Yitzhak Ben-Asouli
  • Publication number: 20080217178
    Abstract: A tank apparatus (10) for horizontal electrophoresis that comprises a base member (12) having at least first and second independent receptacles (16, 18) for accommodating buffer solution. Each of the receptacles comprises an inlet (28, 28?) for allowing communication with the external environment. A cover member (14) covers at least the first and second receptacles, thereby forming first and second buffer chambers. The cover member comprising suitable openings (40, 42) for allowing a portion of an electrophoresis gel cassette to be inserted therethrough, such that the electrophoresis gel is in communication with the contents of each of the first and second receptacles. Each of a pair of electrodes (33, 33?) is situated in one of each of the first and second receptacles, wherein the electrodes are connectable to an electrical power supply.
    Type: Application
    Filed: January 16, 2006
    Publication date: September 11, 2008
    Inventors: Yitzhak Ben-Asouli, Farhart Osman
  • Patent number: 7320747
    Abstract: The present invention is directed to a solidified hybrid gel for use in an electrophoresis process, having a solidified first gel portion juxtaposed with a solidified second gel portion. The first gel portion is capable of accommodating therein one or more samples for electrophoresis after said first gel portion is in solidified form, and the second gel portion is adapted for enabling an electrophoresis process to be applied to such a sample that may be accommodated in said first gel portion. Thus, the hybrid gel may be provided in a precast form to users, ready for use. The invention is also directed to methods for providing such a gel, apparatuses for accommodating such a gel, and methods for carrying out electrophoresis on a sample comprised in such a gel.
    Type: Grant
    Filed: March 8, 2006
    Date of Patent: January 22, 2008
    Assignee: Gene Bio-Application Ltd.
    Inventors: Yitzhak Ben-Asouli, Farhat Osman
  • Patent number: 7279278
    Abstract: A method for orientation-directed construction of a construct including at least two nucleic acid segments of interest. Products are provided having phosphorylated blunt ends derived from the nucleic acid segments of interest. Separate ligation reactions are performed wherein in each reaction the phosphorylated blunt-ended products of two different segments obtained in the previous step are ligated to create a combined ligated sequence. PCR amplification reaction is performed using the combined ligated sequence obtained in the previous step as a template and specific enrichment primers direct the PCR amplification towards the desired orientation. Each combined ligated sequence is amplified in a separate reaction creating a combined product having phosphorylated blunt ends. The combined product is isolated and purified to have the enriched desired orientation.
    Type: Grant
    Filed: August 6, 2003
    Date of Patent: October 9, 2007
    Assignee: Gene Bio-Application Ltd.
    Inventors: Yitzhak Ben-Asouli, Farhat Osman
  • Patent number: 7264703
    Abstract: An apparatus for electrophoresis having a first gel matrix, adapted for performing an electrophoretic process therein, in communication with a second gel matrix, both being accommodated within a suitable housing. The housing has a first opening adapted to permit ionic communication between the first gel matrix and an external ionic buffer solution, and a second opening adapted to permit ionic communication between the second gel matrix and an external ionic buffer solution. The second gel has at least one suitable absorption material capable of retaining therein at least one target substance capable of migrating thereto from the first gel matrix when an electrophoretic process is performed in the first matrix.
    Type: Grant
    Filed: April 23, 2003
    Date of Patent: September 4, 2007
    Assignee: Gene Bio-Application Ltd.
    Inventors: Yitzhak Ben-Asouli, Farhat Osman
  • Publication number: 20060207882
    Abstract: The present invention is directed to a solidified hybrid gel for use in an electrophoresis process, having a solidified first gel portion juxtaposed with a solidified second gel portion. The first gel portion is capable of accommodating therein one or more samples for electrophoresis after said first gel portion is in solidified form, and the second gel portion is adapted for enabling an electrophoresis process to be applied to such a sample that may be accommodated in said first gel portion. Thus, the hybrid gel may be provided in a precast form to users, ready for use. The invention is also directed to methods for providing such a gel, apparatuses for accommodating such a gel, and methods for carrying out electrophoresis on a sample comprised in such a gel.
    Type: Application
    Filed: March 8, 2006
    Publication date: September 21, 2006
    Applicant: GENE BIO-APPLICATION LTD.
    Inventors: Yitzhak Ben-Asouli, Farhat Osman
  • Patent number: 7074313
    Abstract: A device having a processing chamber, for electroelution and/or dialysis of a substance carried in a sample with respect to an external liquid medium. The chamber has a closed end and an opening at the other end, sufficiently large to permit a sample, particularly a gel contained sample, to be inserted thereto. The chamber has two portals, each laterally disposed with respect to the opening. A tubular membrane covers the portals, and is sealingly fixed onto an outside surface of the housing. The device provides high yield recovery, saves time and allows for easy handling, especially regarding loading an unloading of small volume samples for dialysis, or inserting the gel slice containing the macromolecule sample. The device may be partially immersed in the liquid medium, with the opening above the liquid surface. Optionally, the device may be hermetically sealed via a cap, and fully immersed in the liquid medium.
    Type: Grant
    Filed: November 22, 2002
    Date of Patent: July 11, 2006
    Assignee: Gene Bio-Application Ltd.
    Inventors: Yitzhak Ben-Asouli, Farhat Osman
  • Patent number: 7049133
    Abstract: A cis-acting nucleotide sequence which is capable of rendering the removal of introns from a precursor transcript encoded by a gene, which gene harbors at least one such cis-acting nucleotide sequence, occurring during the production of mRNA of a gene, dependent upon activation of a trans-acting factor. The trans-acting factor is an RNA-activated protein kinase which is capable of phosphorylating the ?-subunit of eukaryotic initiation factor 2. The trans-acting factor is preferably, the RNA-activated protein kinase (PKR). The cis-acting nucleotide sequence can be derived from the 3? untranslated region of the human tumor necrosis factor ? gene (TNF-?3?-UTR) and may comprise the nucleotide sequence as denoted by SEQ ID NO:1 or biologically functional fragments, derivatives, mutants and homologues thereof.
    Type: Grant
    Filed: March 7, 2001
    Date of Patent: May 23, 2006
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem
    Inventors: Raymond Kaempfer, Farhat Osman, Nayef Jarrous, Yitzhak Ben-Asouli
  • Publication number: 20040209272
    Abstract: A method for orientation-directed construction of a construct including at least two nucleic acid segments of interest. Products are provided having phosphorylated blunt ends derived from the nucleic acid segments of interest. Separate ligation reactions are performed wherein in each reaction the phosphorylated blunt-ended products of two different segments obtained in the previous step are ligated to create a combined ligated sequence. PCR amplification reaction is performed using the combined ligated sequence obtained in the previous step as a template and specific enrichment primers direct the PCR amplification towards the desired orientation. Each combined ligated sequence is amplified in a separate reaction creating a combined product having phosphorylated blunt ends. The combined product is isolated and purified to have the enriched desired orientation.
    Type: Application
    Filed: August 6, 2003
    Publication date: October 21, 2004
    Inventors: Yitzhak Ben-Asouli, Farhat Osman
  • Publication number: 20040020776
    Abstract: An apparatus for electrophoresis having a first gel matrix, adapted for performing an electrophoretic process therein, in communication with a second gel matrix, both being accommodated within a suitable housing. The housing has a first opening adapted to permit ionic communication between the first gel matrix and an external ionic buffer solution, and a second opening adapted to permit ionic communication between the second gel matrix and an external ionic buffer solution. The second gel has at least one suitable absorption material capable of retaining therein at least one target substance capable of migrating thereto from the first gel matrix when an electrophoretic process is performed in the first matrix.
    Type: Application
    Filed: April 23, 2003
    Publication date: February 5, 2004
    Inventors: Yitzhak Ben-Asouli, Farhat Osman
  • Publication number: 20040020775
    Abstract: A solidified hybrid gel for use in an electrophoresis process that has a solidified first gel portion juxtaposed with a solidified second gel portion. The first gel portion is capable of accommodating therein one or more samples for electrophoresis after said first gel portion is in solidified form, and the second gel portion is adapted for enabling an electrophoresis process to be applied to such a sample that may be accommodated in said first gel portion. Thus, the hybrid gel may be provided in a precast form to users, ready for use. The invention is also directed to methods for providing such a gel, apparatuses for accommodating such a gel, and methods for carrying out electrophoresis on a sample comprised in such a gel.
    Type: Application
    Filed: April 23, 2003
    Publication date: February 5, 2004
    Inventors: Yitzhak Ben-Asouli, Farhat Osman
  • Publication number: 20030133846
    Abstract: A device having a processing chamber, particularly for electroelution and/or dialysis of a substance carried in a sample with respect to an external liquid medium. The chamber is closed at one end and has an opening al the other longitudinal end sufficiently large to permit a sample, and in particular a gel contained sample, to be inserted thereinto. The chamber has a pair of portals laterally disposed with respect to the opening. The portals are covered with a typically tubular membrane, which is sealingly fixed onto an outside surface of the housing defining the chamber, typically by means of a tubular sleeve having portals that align with the portals of the chamber, via an annular sealing arrangement. The device provides high yield recovery, saves time, and allows for relatively easy handling specially regarding loading and unloading of small volume of samples to be dialyzed or inserting the slice of gel containing the macromolecule sample.
    Type: Application
    Filed: November 22, 2002
    Publication date: July 17, 2003
    Inventors: Yitzhak Ben-Asouli, Farhat Osman
  • Publication number: 20020155569
    Abstract: A cis-acting nucleotide sequence which is capable of rendering the removal of introit/s from a precursor transcript encoded by a gene, which gene harbors at least one such cis-acting nucleotide sequence, occurring during the production of mRNA of said gene, dependent upon activation of a trans-acting factor. The trans-acting factor is an RNA-activated protein kinase which is capable of phosphorylated the &agr;-subunit of eucaryotic initiation factor 2, or the RNA-activated protein kinase (PAR). The cis-acting nucleotide sequence can be derived from the 3′ untranslated region of the human tumor necrosis factor &agr; gene (TNF-&agr; 3′-UTR).
    Type: Application
    Filed: March 7, 2001
    Publication date: October 24, 2002
    Inventors: Raymond Kaempfer, Farhat Osman, Nayef Jarrous, Yitzhak Ben-Asouli